“Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up” (2012) Brazilian Journal of Pharmaceutical Sciences, 48(3), pp. 435–446. doi:10.1590/S1984-82502012000300010.